MED2028 FW: Announcement ~ Cancer Center Leadership Updates

[Barbara Glover]

Good afternoon,

Please see the message below regarding important leadership updates for the Upstate Cancer Center.

Please take a moment to review.

Thank you.

Barb Glover, MBA
Executive Assistant to the Senior Vice President and Dean
Lawrence S. Chin, MD, FAANS, FACS
Senior Vice President and Dean, Alan and Marlene Norton College of Medicine
Robert B. and Molly G. King Endowed Professor of Neurosurgery
Interim Director, Upstate Cancer Center
SUNY Upstate Medical University
750 East Adams Street
Syracuse, NY 13210
Tel: 315-464-9723
Email: gloverb at upstate.edu<mailto:gloverb at upstate.edu>

From: Laurie Nicoletti <NICOLETL at upstate.edu>
Sent: Friday, April 17, 2026 12:55 PM
Cc: Barbara Glover <GloverB at upstate.edu>; Lawrence S. Chin <ChinL at upstate.edu>
Subject: Management Forum Announcement ~ Cancer Center Leadership Updates

Dear Team,

To ensure that we have the leadership infrastructure needed to support the continued growth and advancement of the Upstate Cancer Center, we are pleased to share several important leadership updates.

Effective immediately, Dean Chin will serve as Interim Director of the Upstate Cancer Center. Dr. Chin's leadership and commitment to our mission will help guide the Cancer Center through this important period of continued expansion and development.

To further strengthen our Academic Cancer Programs, Dr. Thomas Vandermeer has graciously agreed to assume the role of Deputy Director of Academic Operations. In this position, Dr. Vandermeer will be able to dedicate focused attention to the continued growth of our Cancer Research Programs, while also advancing the integration of clinical trials more seamlessly into our patient care areas. His leadership will be instrumental in expanding our academic and research impact.

In addition, Dr. Jade Homsi has agreed to take on the role of Deputy Director of Clinical Operations. Alongside his responsibilities as Division Chief of Hematology/Oncology, Dr. Homsi will focus on optimizing clinical operations across all Cancer Center sites, helping ensure a consistently exceptional experience for both patients and care teams.

These leadership enhancements reflect our shared commitment to building a strong, collaborative structure that supports innovation, operational excellence, and outstanding patient centered care. Please join us in thanking Dr. Vandermeer, and Dr. Homsi for their willingness to step into these important roles and for their continued dedication to the future of the Upstate Cancer Center.

Warm regards,

Lawrence S. Chin, MD, FAANS, FACS
Senior Vice President and Dean, Alan and Marlene Norton College of Medicine
Robert B. and Molly G. King Endowed Professor of Neurosurgery
Interim Director, Upstate Cancer Center
SUNY Upstate Medical University

Robert J. Corona, DO, MBA, FCAP, FASCP
Chief Executive Officer
John B. Henry Endowed Professor of Pathology and Laboratory Medicine
Sr Associate Dean of Clinical Affairs, SUNY Upstate Alan and Marlene Norton College of Medicine

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.upstate.edu/pipermail/med2028/attachments/20260417/05f22238/attachment.html>